Medical Device News Magazine

SafeSite Takes On COVID-19 with Protocol-Oriented Testing

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 10, 2020

SafeSite, the medical diagnostic, mobile laboratory company, has scaled its west coast-based testing model nationally to help schools, universities, and businesses safely and responsibly reopen. Working with new logistics partner Live Media Group, SafeSite will expand its deployment of mobile laboratories that perform rapid response COVID-19 testing, along with a data-driven personal tracking and contact tracing platform.

SafeSite was formed by an assembly of medical professionals, all frustrated with the lack of cohesive and reliable COVID-19 testing procedures. SafeSite CEO Lauren Rogen Sexton sees an opportunity to change this through a truly protocol-oriented approach that provides results in less than one hour.

SafeSite’s protocol-oriented approach includes creating custom on-site mobile laboratories that give medical personnel a secure environment to administer tests and yield conclusive diagnoses. Applying a multi-pronged approach, SafeSite uses multiple diagnostic methodologies, employing RT-PCR, isothermal amplification, and antigen tests. Results are produced on-site in less than one hour, eliminating the risk of an attendee’s exposure between testing and arrival to alocation or venue.

“There is an immediate need from the community level all the way to nationwide partners for a protocol that is mobile facilities-based, repetitive, and rapid in response. After listening for months to advice from a number of medical and industry experts, including Bill Gates, I took it upon myself to do something instead of sitting ideally by waiting for an effective plan. It is essential to apply multiple diagnostic methods, using the most rigorous FDA-approved tests in combination with an appropriate protocol to safely and confidently reopen schools, companies, sports and entertainment venues,” said Sexton.

The company’s propriety technology platform, SafeSite-PASS, is used by each organization and individual, providing QR Code-based touchless functionality with historical data of all test results stored within user profiles. SafeSite-PASS is a valuable resource for organizations seeking a HIPAA-compliant mobile technology for health monitoring that securely delivers a COVID-19-free business, school or venue location. Beyond a bubble environment, venue setting or group use case, SafeSite-PASS can eventually be used in the general community as evidence of an individual’s health status as well as an effective and productive tracking and tracing tool.

Live Media Group is a natural partner for SafeSite given its extensive corporate, sports and entertainment production expertise, mobile facilities, and logistics experience. This will help SafeSite meet the demand from many clients and verticals, beyond its existing west coast region and headquarters and direct to more populations throughout the United States.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”